Otsuka Holdings
4578.T
#579
Rank
โ‚น3.785 T
Marketcap
โ‚น7,229
Share price
1.93%
Change (1 day)
48.22%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2026 (TTM): โ‚น307.78

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น326.44. In 2025 the company made an earnings per share (EPS) of โ‚น405.88 an increase over its 2024 EPS that were of โ‚น374.09.

EPS history for Otsuka Holdings from 2009 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น307.78-24.17%
2025โ‚น405.888.5%
2024โ‚น374.09153.9%
2023โ‚น147.34-15.71%
2022โ‚น174.79-6.18%
2021โ‚น186.30-24.1%
2020โ‚น245.4722.95%
2019โ‚น199.6456.13%
2018โ‚น127.87-25.11%
2017โ‚น170.7625.99%
2016โ‚น135.54-6.37%
2015โ‚น144.76
2014N/A-100%
2013โ‚น218.1118.06%
2012โ‚น184.741.01%
2011โ‚น182.8829.07%
2010โ‚น141.70-94.47%
2009โ‚น2,562